These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18708403)

  • 1. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
    Wang X; Goode EL; Fredericksen ZS; Vierkant RA; Pankratz VS; Liu-Mares W; Rider DN; Vachon CM; Cerhan JR; Olson JE; Couch FJ
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2101-8. PubMed ID: 18708403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AXIN2 Polymorphisms, the β-Catenin Destruction Complex Expression Profile and Breast Cancer Susceptibility.
    Aristizabal-Pachon AF; Carvalho TI; Carrara HH; Andrade J; Takahashi CS
    Asian Pac J Cancer Prev; 2015; 16(16):7277-84. PubMed ID: 26514524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer.
    Rosales-Reynoso MA; Saucedo-Sariñana AM; Contreras-Díaz KB; Márquez-González RM; Barros-Núñez P; Pineda-Razo TD; Marin-Contreras ME; Durán-Anguiano Ó; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
    Tohoku J Exp Med; 2019 Nov; 249(3):173-183. PubMed ID: 31723073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients.
    Alanazi MS; Parine NR; Shaik JP; Alabdulkarim HA; Ajaj SA; Khan Z
    PLoS One; 2013; 8(3):e59555. PubMed ID: 23516639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of APC and MCC polymorphisms with increased breast cancer risk in an Indian population.
    Mukherjee N; Bhattacharya N; Sinha S; Alam N; Chakravarti R; Roychoudhury S; Panda CK
    Int J Biol Markers; 2011; 26(1):43-9. PubMed ID: 21279955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between
    Dai J; Gao H; Xue J; Lin W; Zheng L
    Genet Test Mol Biomarkers; 2019 Jun; 23(6):393-400. PubMed ID: 31063404
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of WNT Pathway Genes With Nonsyndromic Cleft Lip With or Without Cleft Palate.
    Vijayan V; Ummer R; Weber R; Silva R; Letra A
    Cleft Palate Craniofac J; 2018 Mar; 55(3):335-341. PubMed ID: 29437498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
    Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
    Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
    Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
    J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
    Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
    Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.
    Yadav A; Gupta A; Yadav S; Rastogi N; Agrawal S; Kumar A; Kumar V; Misra S; Mittal B
    Tumour Biol; 2016 Jun; 37(6):8083-95. PubMed ID: 26715268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.
    Feigelson HS; Teras LR; Diver WR; Tang W; Patel AV; Stevens VL; Calle EE; Thun MJ; Bouzyk M
    Breast Cancer Res; 2008; 10(4):R57. PubMed ID: 18611262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.
    Koppert LB; van der Velden AW; van de Wetering M; Abbou M; van den Ouweland AM; Tilanus HW; Wijnhoven BP; Dinjens WN
    Br J Cancer; 2004 Feb; 90(4):892-9. PubMed ID: 14970870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in components of the Wnt signaling pathway in gastric cancer.
    Pan KF; Liu WG; Zhang L; You WC; Lu YY
    World J Gastroenterol; 2008 Mar; 14(10):1570-4. PubMed ID: 18330950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
    Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
    Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.
    Pierzynski JA; Hildebrandt MA; Kamat AM; Lin J; Ye Y; Dinney CP; Wu X
    J Urol; 2015 Dec; 194(6):1771-6. PubMed ID: 26173102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.